E-LIB Suche - Ergebnisse für: Pogue, Jason M

1

Tebipenem and Sulopenem: Dynamic Duo or Double Trouble?:

Mangum, Blake R. ; Pogue, Jason M. ; Barber, Katie E.
Current Infectious Disease Reports. 26 (2024) 5 - p. 139-150 , 2024

Link: https://doi.org/10.1007/..

2

Population pharmacokinetic/pharmacodynamic target attainmen..:

Wangchinda, Walaiporn ; Pogue, Jason M ; Thamlikitkul, Visanu...
Journal of Antimicrobial Chemotherapy. 79 (2024) 6 - p. 1372-1379 , 2024

Link: https://doi.org/10.1093/..

3

A comparison of strategies for identifying patients at risk..:

Wangchinda, Walaiporn ; Kaye, Keith S ; Patel, Twisha S...
Journal of Antimicrobial Chemotherapy. 79 (2024) 6 - p. 1337-1345 , 2024

Link: https://doi.org/10.1093/..

4

Is it time to join the oral antibiotics bandwagon?:

Justo, Julie Ann ; Pogue, Jason M
The Lancet Infectious Diseases. 24 (2024) 5 - p. 445-447 , 2024

Link: https://doi.org/10.1016/..

5

The Growing Threat of NDM-Producing E. Coli With Penicillin..:

Aitken, Samuel L ; Pierce, Virginia M ; Pogue, Jason M...
Clinical Infectious Diseases. , 2024

Link: https://doi.org/10.1093/..

6

356. Impact of CLSI Breakpoint Changes on Unit-Specific Com..:

Wangchinda, Walaiporn ; Aitken, Samuel L ; Pierce, Virginia M..
Open Forum Infectious Diseases. 10 (2023) Supplement_2 - p. , 2023

Link: https://doi.org/10.1093/..

7

Executive Summary: State-of-the-Art Review: State of the Ma..:

Yassin, Arsheena ; Huralska, Mariya ; Pogue, Jason M...
Clinical Infectious Diseases. 77 (2023) 9 - p. 1223-1225 , 2023

Link: https://doi.org/10.1093/..

8

2186. Treatment-emergent resistance to ceftazidime-avibacta..:

Shah, Sunish ; Haidar, Ghady ; Squires, Kevin M...
Open Forum Infectious Diseases. 10 (2023) Supplement_2 - p. , 2023

Link: https://doi.org/10.1093/..

9

Cefiderocol, a Siderophore Cephalosporin, as a Treatment Op..:

Kaye, Keith S. ; Naas, Thierry ; Pogue, Jason M..
Infectious Diseases and Therapy. 12 (2023) 3 - p. 777-806 , 2023

Link: https://doi.org/10.1007/..

10

355. Stratification of Patient-Specific Risk Factors for Mu..:

Wangchinda, Walaiporn ; Aitken, Samuel L ; Lephart, Paul.
Open Forum Infectious Diseases. 10 (2023) Supplement_2 - p. , 2023

Link: https://doi.org/10.1093/..

11

2474. Emergence of Candida auris in Michigan:

McNamara, Sara E ; Brennan, Brenda M ; Mach, Niki...
Open Forum Infectious Diseases. 10 (2023) Supplement_2 - p. , 2023

Link: https://doi.org/10.1093/..

12

1764. Collaboration between Public Health and Healthcare Pa..:

Brennan, Brenda M ; McNamara, Sara E ; Stier, Elisia...
Open Forum Infectious Diseases. 10 (2023) Supplement_2 - p. , 2023

Link: https://doi.org/10.1093/..

13

976. Population Pharmacokinetic/Pharmacodynamic (PK/PD) Tar..:

Wangchinda, Walaiporn ; Pogue, jason M ; Thamlikitkul, Visanu...
Open Forum Infectious Diseases. 10 (2023) Supplement_2 - p. , 2023

Link: https://doi.org/10.1093/..

14

2550. Comparing Efficacy of Serum and Epithelial Lining Flu..:

Lavoie, Thomas ; Daffinee, Katie ; Pogue, jason M..
Open Forum Infectious Diseases. 10 (2023) Supplement_2 - p. , 2023

Link: https://doi.org/10.1093/..

15

State of the Management of Infections Caused by Multidrug-R..:

Yassin, Arsheena ; Huralska, Mariya ; Pogue, Jason M...
Clinical Infectious Diseases. 77 (2023) 9 - p. e46-e56 , 2023

Link: https://doi.org/10.1093/..